References
- Sipp D . The unregulated commercialization of stem cell treatments: a global perspective . Front. Med. 5 ( 4 ), 348 – 355 ( 2011 ).
- Ogbogu U , Rachul C , Caulfield T . Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better ? Regen. Med. 8 ( 3 ), 361 – 369 ( 2013 ).
- Sina, . The Mess of Stem Cell Treatment . http://news.sina.com.cn/c/sd/2012-09-07/105725122461.shtml
- Cohen CB , Cohen PJ . International stem cell tourism and need for effective regulation. Part I: stem cell tourism in Russia and India: clinical research, innovative treatment, or unproven hype? Kennedy Inst. Ethics J. 20 ( 1 ), 27 – 49 ( 2010 ).
- Patra PK , Sleeboom-Faulkner M . Bionetworking: between guidelines and practice in stem cell therapy enterprise in India . SCRIPTed 7 ( 2 ), 295 – 310 ( 2010 ).
- Science and Technology Select Committee: Regenerative Medicine Oral and Written Evidence, House of Lord. www.parliament.uk/documents/lords-committees/science-technology/RegenerativeMedicine/RegenMed.pdf
- More Stem Cell Therapies to be Launched in Next Five Years, Pharmabiz. www.pharmabiz.com/ArticleDetails.aspx?aid=73322&sid=11
- METI, . On the New Regenerative Medicines Law . www.lifescience.mext.go.jp/files/pdf/n1183_09.pdf
- Unknown Territory. Editorial. Nature. www.nature.com/news/unknown-territory-1.12360
- McKay R . Stem cells – hype and hope . Nature 406 , 361 – 364 ( 2000 ).
- Morrison M . Promissory futures and possible pasts: the dynamics of contemporary expectations in contemporary medicine . Biosocieties 7 , 3 – 22 ( 2012 ).
- Murdoch CE , Scott CT . Stem cell tourism and the power of hope . Am. J. Bioeth. 5 ( 10 ), 16 – 23 ( 2010 ).
- Knowles L.Stem Cell Hype and the Dangers of Stem Cell Tourism. Stem Cell Network, For the Public, Ethics and Policy, Spring (2010). www.stemcellnetwork.ca/uploads/File/whitepapers/Stem-Cell-Hype.pdf
- Epstein S. Impure Science: AIDS, Activism, and the Politics of Knowledge. University of California Press , CA, USA ( 1996 ).
- Abbott A . Stem cell ruling riles researchers . Nature 495 , 418 – 419 ( 2013 ).
- Margotini L . Italian Parliament Orders Clinical Trial of Controversial Stem Cell Treatment . 22 May 2013 . http://news.sciencemag.org/europe/2013/05/italian-parliament-orders-clinical-trial-controversial-stem-cell-treatment
- univerCellmarket. Italian stem-cell trial based on flawed data (2013). www.univercellmarket.com/@offers/news/view/3759
- Margottini L . No Point in Testing Controversial Stem Cell Treatment, Italian Panel Says ( 2013 ). http://news.sciencemag.org/biology/2013/09/no-point-testing-controversial-stem-cell-treatment-italian-panel-says
- Japan Times. Bills Passed on Regenerative Meds (2013). www.japantimes.co.jp/news/2013/11/20/national/bills-passed-on-regenerative-meds/#.UpjaltKaKSp
- Globenewswire. New Japanese Regenerative Medicine Legislation and Commercial Opportunities for Stem Cell Products. http://finance.yahoo.com/news/japanese-regenerative-medicine-legislation-commercial-001627681.html
- Lau D , Ogbogu U , Taylor B , Stafinski T , Menon D , Caulfield T . Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine . Cell Stem Cell 3 , 591 – 594 ( 2008 ).
- Ryan KA , Sanders AN , Wang DD , Levine AD . Tracking the rise of stem cell tourism . Regen. Med. 5 , 27 – 33 ( 2010 ).
- Levine AD . Insights from patients’ blogs and the need for systematic data on stem cell tourism . Am. J. Bioeth. 10 ( 5 ), 28 – 29 ( 2010 ).
- Qiu R , Zhai X . On the ethical supervision and control of stem cell research and clinical application . Chinese Medical Ethics 22 ( 5 ), 3 – 9 ( 2009 ).
- Cohen CB , Cohen PJ . International stem cell tourism and the need for effective regulation. Part II: developing sound oversight measures and effective patient support . Kennedy Inst. Ethics J. 20 ( 3 ), 207 – 230 ( 2010 ).
- Webster A , Haddad C , Waldby C . Experimental heterogeneity and standardisation: stem cell products and the clinical trial process . Biosocieties 6 ( 4 ), 401 – 419 ( 2011 ).
- Alliance for Advanced Therapies . Focus hospital exemption on developing innovative and safe treatments for patients . Regen. Med. 8 ( 2 ), 121 – 123 ( 2013 ).
- Mahalatchimy A , Rial-Sebbag E , Tournay V , Faulkner A . The legal landscape for advanced therapies: material and institutional implementation of European Union rules in France and the United Kingdom . J. Law Soc. 39 ( 1 ), 131 – 149 ( 2012 ).
- Lindvall O , Hyun I . Medical innovation versus stem cell tourism . Science 1664 – 1665 ( 2009 ).
- Gunter KC , Caplan AL , Mason C et al. Cell therapy medical tourism: time for action . Cytotherapy 12 ( 8 ), 965 – 968 ( 2010 ).
- The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, US Department of Health, Education and Welfare (1979). Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Belmont Report. www.hhs.gov/ohrp/humansubjects/guidance/belmont.html#go3
- Hicks D Katz J . Hospitals: the hidden research system . Sci. Public Policy 23 ( 5 ), 297 – 304 ( 1996 ).
- Hopkins M . The hidden research system; the evolution of cytogenetic testing in the National Health Service . Sci. Cult. 15 ( 3 ), 253 – 275 ( 2006 ).
- National Health Service Blood and Transplant. Stem Cells Services (2013). www.nhsbt.nhs.uk/stemcells/stem_cells_services
- Brown N , Kraft A , Martin P . The promissory pasts of blood stem cells . BioSocieties 1 ( 3 ), 329 – 348 ( 2006 ).
- Daley GQ , Scadden DT . Prospects for stem cell therapy . Cell 132 ( 4 ), 544 – 548 ( 2008 ).
- European Commission, Health and Consumers Directorate General, Pharmaceutical Committee (2012). Hospital Exemption for ATMPs (implementation of Art 28(2) of Regulation 1394/2007): Update on Feedback Received by the Commission. Pharm 608. http://ec.europa.eu/health/files/advtherapies/2013_05_pc_atmp/07_2_pc_atmp_2013.pdf
- ClinicalTrials.gov.
- PRLOG. RNL Bio opens its second stem cell clinic in Yanji, China (2013). www.prlog.org/10140739-rnl-bio-opens-its-second-stem-cell-clinic-in-yanji-china.html
- International Stem Cell Forum. ISCF member updates: China (2013). www.stem-cell-forum.net/chinese-academy-of-sciences
- China Ministry of Health and China Food and Drugs Administration . Stem Cell Research Measures for the Administration of Clinical Trials. Ministry of Health ( 2013 ). www.moh.gov.cn/wsb/pzcjd/201303/022ce8030a36442bab563d07c57faf1b.shtml
- Russia Ministry of Health. Federal Law on Biomedical Cell Technologies (2013). (Draft, under consideration by State Duma). www.rosminzdrav.ru/docs/doc_projects/905
- India Council of Medical Research, Department of Health Research, Department of Biotechnology. Guidelines for Stem Cell Research. (2012). www.icmr.nic.in/stem_cell_guidelines.pdf
- Zatz M . Stem cell researches in Brazil: present and future challenges . Stem Cell Rev. 5 ( 2 ), 123 – 129 ( 2009 ).
- Arellano M . The rise of stem cell therapies in Mexico: inadequate regulation or unsuccessful oversight? Revista Redbioetica UNESCO, Ano 3 2 ( 6 ), 63 – 78 ( 2012 ).
- Santiago-Rodriguez F . Governing ethical clinical research in developing countries: exploring the case of Mexico . Sci. Public Policy 37 ( 8 ), 583 – 596 ( 2010 ).
- Cyranoski D . Stem cell therapy takes off in Texas . Nature 483 , 13 – 14 ( 2012 ).
- Cyranoski D . Stem cells in Texas: cowboy culture . Nature 494 , 166 – 168 ( 2013 ).
- Preventive therapy. Stem-cell trials must be made easier, so that treatments can be based on real data . Nature 494 , 147 – 148 ( 2013 ).
- Park M . Texas Board Approves Rules on Use of Stem Cells . New York Times. 13 April 2012 . www.nytimes.com/2012/04/14/us/new-rules-on-adult-stem-cells-approved-in-texas.html?_r=0
- National Stem Cells Foundation of Australia and Stem Cells Australia. The Australian Stem Cell Hand book (2013). www.stemcellfoundation.net.au/docs/patient-handbook/the-australian-stem-cell-handbook.pdf?sfvrsn=4
- Egami M . [Efforts to Resolve Barriers to Commercialisation in Regenerative Medicine] . In: [Regenerative Medicine from the Standpoint of Manufacturing Technologies] . CMC , Tokyo, Japan , 261 – 262 ( 2011 ).
- Eriksson L , Webster A . Standardising the unknown: practicable pluripotency as doable futures . Sci. Cult. 17 ( 1 ), 57 – 69 ( 2008 ).
- Waldby C , Salter B . Global governance in human embryonic stem cell science: standardisation and bioethics in research and patenting . Stud. Ethics Law Technol. 2 ( 1 ), 1 – 23 ( 2008 ).
- UK Medical Research Council and the National Natural Science Foundation of China (2013). UK–China Stem Cell Research Collaboration. www.mrc.ac.uk/Fundingopportunities/Calls/UK-China13/MRC008973
- International Society for Stem Cell Research. Guidelines for the Clinical Translation of Stem Cells (2008). www.isscr.org/docs/default-source/clin-trans-guidelines/isscrglclinicaltrans.pdf
- American Association of Blood Banks (2011). AABB Enters Partnership with International Cellular Therapy Society. www.aabb.org/events/annualmeeting/attendees/64amonline/Pages/saturday_partnership.aspx
- NHS Blood and Transplant Special Health Authority. www.nhsbt.nhs.uk/stemcells/index.asp
- Brain and Spine Foundation. www.brainandspine.org.uk/future-treatments-transverse-myelitis
- Parkinson’s UK. www.parkinsons.org.uk/content/future-treatments
- Arthritis Research UK. www.arthritisresearchuk.org/news/general-news/2010/september/warning-against-foreign-stem-cell-clinics.aspx
- Stem Cell Therapies and MS. Multiple Sclerosis Society. www.mstrust.org.uk/atoz/stem_cells.jsp?gclid=CO7hmaWFl74CFcbKtAodZDcADw
- Diabetes UK. www.diabetes.org.uk/Research/Our-approach-to-research/Research-position-statements/Stem_cell_research_and_diabetes
- Thorley S. Stem Cell Treatment: Stella Thorley Follow-Up. 75, 40-42 (2012). www.ms-uk.org/files/npwm_2012_0075.pdf
- Turner C. Carmel’s Stem Cell Story. New Pathways. 69, 18–20 (2011). www.ms-uk.org/files/npwm_2011_0069.pdf
- Cook I. Websites Roundup. New Pathways. 72, 50–52 (2012). www.ms-uk.org/files/npwm_2012_0072.pdf
- House of Lords Science and Technology Committee.Regenerative Medicine. 1st Report of Session 2013–70. Stationery Office Ltd , London, UK ( 2013 ).
- Ethical Guidelines for Innovative Surgery. Reitsma AM , MorenoJD ( Eds ). University Publishing Group , MD, USA ( 2006 ).
- American College of Obstetricians and Gynaecologists, Committee on Ethics. Innovative Practice: Ethical Guidelines. ACOG Committee Opinion No 352 (2006). www.acog.org/∼/media/Committee%20Opinions/Committee%20on%20Ethics/co352.pdf?dmc=1&ts=20130813T0658170984
- Taylor PL . Overseeing innovative therapy without mistaking it for research: a function based model based on old truths, new capacities, and lessons from stem cells . J. Law Med. Ethics 38 ( 2 ), 286 – 302 ( 2010 ).
- Mason C , Manzotti E . Defeating stem cell tourism . Regen. Med. 5 ( 5 ), 681 – 686 ( 2010 ).